Using Proteomics to Enable the Adaptive and Innate Immune Response in Vaccines against COVID-19

Proteomics

Using Proteomics to Enable the Adaptive and Innate Immune Response in Vaccines against COVID-19

Featured Speaker: Moriya Tsuji, MD, PhD, Professor of Medicine at Aaron Diamond AIDS Research Center, Columbia University

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Webinar we discuss:

Using more predictive single cell proteomics in mouse models to understand correlative T cell potency in infectious disease vaccines

Understanding of more predictive T cell potency in mouse models important for understanding vaccine development

The challenges in pre-clinical vaccine development today that can be overcome by having potency tools and better ways to characterize human immune response

Explore Related Resources

Access related webinars, eBooks, app notes & case studies.

Webinar

Highly Multiplexed Single-Cell Proteomics Identifies Key Inflammatory Mediators in Severe COVID-19

Paper Summary

Immune-cell Functional Profiling Sheds Light on the Pathogenesis of Severe COVID-19

Webinar

Improving COVID-19 Treatment & Vaccine Development by Modulating the Immune Response: Applying Single-Cell Proteomics

Watch the Webinar

Back to the Top